Aptus Pharma Ltd Financials
Company Logo

Aptus Pharma Ltd Financial Statement

Aptus Pharma Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Aptus Pharma Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Total Revenue Annual24.56
Operating Expenses Annual19.71
Operating Profit Annual4.93
Interest Annual0.47
Depreciation0.27
Net Profit Annual3.10
Tax Annual1.10

Aptus Pharma Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Cash Flow at the Beginning0.91
Cash Flow from Operations-1.84
Cash Flow from Investing-0.54
Cash Flow from Financing6.68
Cash Flow at the End5.21

Aptus Pharma Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
PBDIT Margin (%)20.07
PBIT Margin (%)18.97
PBT Margin (%)-21.50
Net PROFIT Margin (%)12.62
Return On Networth / Equity (%)70.94
Return On Networth /Employed (%)37.63
Return On Assets (%)24.99
Total Debt / Equity (X)1.79
Asset Turnover Ratio (%)1.98

Aptus Pharma Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2025
Fixed Assets Annual0.99
Total Current Assets Annual19.74
Non Current Assets Annual2.18
Total Shareholders Funds Annual6.97
Total Assets Annual21.92

Aptus Pharma Ltd Earning Calls

No Data Availabe

FAQS on Aptus Pharma Ltd Financials

As of Sep 30, 2025, Aptus Pharma Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.

Yes, Aptus Pharma Ltd is not with a debt-to-equity ratio of 1.49.

In FY 2024 , Aptus Pharma Ltd recorded a total revenue of approximately 24.56 Cr marking a significant milestone in the company's financial performance.

Aptus Pharma Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and 0.3% annually, respectively..

Aptus Pharma Ltd's current PE ratio is .

Aptus Pharma Ltd's ROCE averaged 20.0% from the FY ending March 2023 to 2025, with a median of 19.2%. It peaked at 26.9% in March 2025, reflecting strong capital efficiency over the period..

Aptus Pharma Ltd's latest EBIT is Rs. 4.67 Cr, surpassing the average EBIT of Rs. 2.16 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions